Your browser doesn't support javascript.
loading
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
Balasubramanian, Akhila; Kulasingam, Shalini L; Baer, Atar; Hughes, James P; Myers, Evan R; Mao, Constance; Kiviat, Nancy B; Koutsky, Laura A.
Affiliation
  • Balasubramanian A; Department of Epidemiology, University of Washington, Seattle, WA, USA. akhilab@amgen.com
J Low Genit Tract Dis ; 14(3): 185-95, 2010 Jul.
Article in En | MEDLINE | ID: mdl-20592553
ABSTRACT

OBJECTIVE:

Estimate the accuracy and cost-effectiveness of cervical cancer screening strategies based on high-risk human papillomavirus (HPV) DNA testing of self-collected vaginal samples. MATERIALS AND

METHODS:

A subset of 1,665 women (age range, 18-50 y) participating in a cervical cancer screening study were screened by liquid-based cytology and by high-risk HPV DNA testing of both self-collected vaginal swab samples and clinician-collected cervical samples. Women with positive/abnormal screening test results and a subset of women with negative screening test results were triaged to colposcopy. On the basis of individual and combined test results, 5 screening strategies were defined. Estimates of sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or worse were calculated, and a Markov model was used to estimate the incremental cost-effectiveness ratios for each strategy.

RESULTS:

Compared with cytology-based screening, high-risk HPV DNA testing of self-collected vaginal samples was more sensitive (68%, 95% CI = 58%-78% vs 85%, 95% CI = 76%-94%) but less specific (89%, 95% CI = 86%-91% vs 73%, 95% CI = 67%-79%). A strategy of high-risk HPV DNA testing of self-collected vaginal samples followed by cytology triage of HPV-positive women was comparably sensitive (75%, 95% CI = 64%-86%) and specific (88%, 95% CI = 85%-92%) to cytology-based screening. In-home self-collection for high-risk HPV DNA detection followed by in-clinic cytology triage had a slightly lower lifetime cost and a slightly higher quality-adjusted life year (QALY) expectancy than did cytology-based screening (incremental cost-effectiveness ratio of triennial screening compared with no screening was $9,871/QALY and $12,878/QALY, respectively).

CONCLUSIONS:

Triennial screening by high-risk HPV DNA testing of in-home, self-collected vaginal samples followed by in-clinic cytology triage was cost-effective.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Specimen Handling / Vagina / Uterine Cervical Neoplasms / Papillomavirus Infections / Early Detection of Cancer Type of study: Diagnostic_studies / Etiology_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: J Low Genit Tract Dis Journal subject: GINECOLOGIA Year: 2010 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Specimen Handling / Vagina / Uterine Cervical Neoplasms / Papillomavirus Infections / Early Detection of Cancer Type of study: Diagnostic_studies / Etiology_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: J Low Genit Tract Dis Journal subject: GINECOLOGIA Year: 2010 Type: Article Affiliation country: United States